Current Research Focus in Clinical Neuropsychiatry: Translational and Therapeutic Perspectives

A Special Issue of Clinics and Practice (ISSN 2039-7283).

Deadline for manuscript submissions: 31 July 2027 | Viewed by 56

Editor


E-Mail Website
Guest Editor
Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, Jane and Terry Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles, CA, USA
Interests: neuroscience; psychology; psychiatry; pharmacology

Special Issue Information

Dear Colleagues,

Clinical neuropsychiatry sits at the intersection of neurology and psychiatry, addressing conditions in which disordered brain function drives both cognitive and affective symptoms. Despite rapid progress in neuroscience, translating mechanistic insight into measurable clinical benefit remains slow. Diagnosis still leans heavily on subjective assessment, treatment selection is often trial-and-error, and objective markers to track therapeutic response are scarce. Meanwhile, the global burden of neuropsychiatric disorders continues to rise, straining health systems and widening gaps in access to specialist care. These pressures create both urgency and opportunity: emerging tools such as portable neurophysiological monitoring, digital biomarkers, neuromodulation, and novel pharmacotherapies are beginning to bridge the divide between laboratory discovery and routine practice.

This Special Issue aims to present and disseminate the most recent advances related to translational and therapeutic approaches in clinical neuropsychiatry. We consider contributions that connect biological mechanisms to clinical outcomes, validate objective markers of brain health, and evaluate innovative or personalized interventions across neuropsychiatric conditions. Original research, reviews, and short communications are welcome.

Topics of interest for publication include, but are not limited to, the following:

  • Mobile and wearable EEG for assessing markers of brain health across neuropsychiatric treatments
  • Digital biomarkers and remote monitoring of treatment response
  • Neuromodulation therapies (e.g., rTMS, tDCS) and their mechanisms of action
  • Novel and rapid-acting pharmacotherapies (e.g., ketamine, psychedelic-assisted approaches)
  • Personalized and precision-psychiatry frameworks
  • Translational biomarkers bridging preclinical models and clinical outcomes
  • Electrophysiological and neuroimaging correlates of psychiatric diagnosis and prognosis
  • Integration of AI/machine learning into neuropsychiatric assessment

Dr. Conor H. Murray
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Clinics and Practice is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • neuropsychiatry
  • biomarkers
  • neuroimaging
  • machine learning
  • precision medicine

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers

This special issue is now open for submission.
Back to TopTop